DIFLUNISAL
- Product NDC
- 64980-181
- 11-digit product format
- 649800181
- Labeler code
- 64980
- Product ID
- 64980-181_5a68ac1c-94bd-4583-8c87-38618bd3f2a0
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- DIFLUNISAL
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Rising Pharmaceuticals Inc.
- Application
- ANDA202845
- Marketing category
- ANDA
- Marketing start
- 2012-05-01
- Marketing end
- 0000-00-00
- Substance
- DIFLUNISAL
- Active strength
- 500 mg/1
- Pharmacologic classes
- Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 64980-181-01 | 64980018101 | 100 TABLET, FILM COATED in 1 BOTTLE (64980-181-01) | 2012-05-01 | 0000-00-00 | No | No | Current |
| 64980-181-05 | 64980018105 | 500 TABLET, FILM COATED in 1 BOTTLE (64980-181-05) | 2012-05-01 | 0000-00-00 | No | No | Current |
| 64980-181-06 | 64980018106 | 60 TABLET, FILM COATED in 1 BOTTLE (64980-181-06) | 2012-05-01 | 0000-00-00 | No | No | Current |